Curi RMB Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $416K | Sell |
1,419
-20
| -1% | -$6.57K | 0.01% | 642 |
|
|
2025
Q4 | $505K | Sell |
1,439
-75
| -5% | -$25.3K | 0.01% | 606 |
|
|
2025
Q3 | $489K | Sell |
1,514
-169
| -10% | -$52.6K | 0.01% | 516 |
|
|
2025
Q2 | $655K | Buy |
+1,683
| New | +$677K | 0.01% | 472 |
|
|
2025
Q1 | – | Sell |
-2,042
| Closed | -$753K | – | 493 |
|
|
2024
Q4 | $753K | Sell |
2,042
-254
| -11% | -$106K | 0.02% | 365 |
|
|
2024
Q3 | $1.19M | Sell |
2,296
-270
| -11% | -$144K | 0.03% | 322 |
|
|
2024
Q2 | $1.39M | Sell |
2,566
-419
| -14% | -$221K | 0.03% | 306 |
|
|
2024
Q1 | $1.55M | Buy |
2,985
+5
| +0.2% | +$2.49K | 0.04% | 301 |
|
|
2023
Q4 | $1.41M | Buy |
2,980
+102
| +4% | +$47.2K | 0.04% | 265 |
|
|
2023
Q3 | $1.25M | Sell |
2,878
-162
| -5% | -$73.5K | 0.04% | 262 |
|
|
2023
Q2 | $1.35M | Sell |
3,040
-185
| -6% | -$85.3K | 0.04% | 255 |
|
|
2023
Q1 | $1.48M | Sell |
3,225
-299
| -8% | -$142K | 0.05% | 247 |
|
|
2022
Q4 | $1.81M | Sell |
3,524
-103
| -3% | -$52.3K | 0.06% | 225 |
|
|
2022
Q3 | $1.65M | Buy |
3,627
+117
| +3% | +$56K | 0.06% | 238 |
|
|
2022
Q2 | $1.69M | Buy |
3,510
+120
| +4% | +$59.4K | 0.06% | 231 |
|
|
2022
Q1 | $1.67M | Buy |
3,390
+386
| +13% | +$176K | 0.05% | 206 |
|
|
2021
Q4 | $1.39M | Sell |
3,004
-40
| -1% | -$16.8K | 0.04% | 237 |
|
|
2021
Q3 | $1.14M | Sell |
3,044
-208
| -6% | -$79K | 0.04% | 262 |
|
|
2021
Q2 | $1.24M | Buy |
3,252
+393
| +14% | +$150K | 0.04% | 260 |
|
|
2021
Q1 | $1.03M | Sell |
2,859
-14
| -0.5% | -$4.5K | 0.04% | 262 |
|
|
2020
Q4 | $922K | Hold |
2,873
| – | – | 0.03% | 324 |
|
|
2020
Q3 | $772K | Sell |
2,873
-344
| -11% | -$92.6K | 0.03% | 345 |
|
|
2020
Q2 | $846K | Sell |
3,217
-341
| -10% | -$91K | 0.04% | 319 |
|
|
2020
Q1 | $808K | Buy |
3,558
+168
| +5% | +$45.8K | 0.04% | 319 |
|
|
2019
Q4 | $1.02M | Buy |
3,390
+181
| +6% | +$49.8K | 0.03% | 360 |
|
|
2019
Q3 | $770K | Sell |
3,209
-605
| -16% | -$166K | 0.02% | 429 |
|
|
2019
Q2 | $1.08M | Sell |
3,814
-711
| -16% | -$194K | 0.03% | 401 |
|
|
2019
Q1 | $1.3M | Sell |
4,525
-57
| -1% | -$16.5K | 0.03% | 410 |
|
|
2018
Q4 | $1.2M | Sell |
4,582
-124
| -3% | -$34.1K | 0.03% | 462 |
|
|
2018
Q3 | $1.29M | Buy |
4,706
+60
| +1% | +$15.6K | 0.03% | 463 |
|
|
2018
Q2 | $1.11M | Buy |
4,646
+757
| +19% | +$175K | 0.03% | 472 |
|
|
2018
Q1 | $854K | Sell |
3,889
-9,151
| -70% | -$2.15M | 0.02% | 535 |
|
|
2017
Q4 | $2.93M | Sell |
13,040
-5,485
| -30% | -$1.17M | 0.08% | 317 |
|
|
2017
Q3 | $3.52M | Buy |
18,525
+2,318
| +14% | +$441K | 0.09% | 293 |
|
|
2017
Q2 | $3.05M | Buy |
16,207
+13,025
| +409% | +$2.34M | 0.09% | 304 |
|
|
2017
Q1 | $526K | Buy |
3,182
+249
| +8% | +$39.6K | 0.02% | 367 |
|
|
2016
Q4 | $422K | Buy |
2,933
+833
| +40% | +$112K | 0.02% | 332 |
|
|
2016
Q3 | $263K | Sell |
2,100
-26
| -1% | -$3.36K | 0.01% | 356 |
|
|
2016
Q2 | $279K | Buy |
2,126
+495
| +30% | +$67.7K | 0.01% | 362 |
|
|
2016
Q1 | $227K | Hold |
1,631
| – | – | 0.01% | 333 |
|
|
2015
Q4 | $227K | Hold |
1,631
| – | – | 0.01% | 386 |
|
|
2015
Q3 | $228K | Sell |
1,631
-11
| -0.7% | -$1.65K | 0.02% | 393 |
|
|
2015
Q2 | $270K | Buy |
1,642
+11
| +0.7% | +$1.76K | 0.02% | 362 |
|
|
2015
Q1 | $252K | Hold |
1,631
| – | – | 0.02% | 433 |
|
|
2014
Q4 | $205K | Buy |
+1,631
| New | +$202K | 0.01% | 419 |
|
Other funds holding ELV
VCM
VPM
Curi RMB Capital's ELV Position: Q1 2026 in Review
Curi RMB Capital reduced its Elevance Health (ELV) stake by 1.4% in Q1 2026, selling an estimated $6.57K and leaving 1,419 shares worth $416K. The position accounts for 0.01% of the portfolio, ranked #642.
Curi RMB Capital first reported a position in ELV in Q4 2014 and has held it in 45 quarters since. The position peaked at $3.52M in Q3 2017. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Curi RMB Capital held 1,419 shares of Elevance Health worth $416K as of Q1 2026.
- Curi RMB Capital sold 20 Elevance Health shares in Q1 2026, an estimated $6.57K.
- Elevance Health made up 0.01% of Curi RMB Capital's portfolio in Q1 2026, its #642 holding.
- Curi RMB Capital first reported a position in Elevance Health in Q4 2014 and has held it in 45 quarters since.
- Curi RMB Capital's Elevance Health position peaked at $3.52M in Q3 2017.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.